New Medicines: Better Outcomes?

Published: 20-Jan-2016

21 April 2016

ABPI Annual Conference and Dinner

London, UK


This year the ABPI's annual conference will discuss three core themes:

  • In the world of global medicines development, how does the UK become a world-leader in the new medicines that are on the horizon?
  • From a policy perspective, can we transform the way patients interact with medicines across the development and treatment pathways?
  • How can industry work in partnership with the NHS to make the new medicines opportunity real and drive better health for patients?

Organiser: Association of the British Pharmaceutical Industry (ABPI)

Trending Articles

  1. CPhI North America 7-9 May 2024 | Exhibition | Pennsylvania, US
  2. Cleanroom Conference UK 22–23 May 2024 | Exhibition | Birmingham, UK
  3. ASGCT Annual Meeting 2024 7-11 May, 2024 | Meeting | Portland, OR
  4. CPhI South East Asia 2024 10-12 July 2024 | Exhibition and Conference | Bangkok, Thailand
  5. Lounges 23-25 April 2024 | Conference | Messe Karlsruhe, Germany

You may also like

Research & Development

ABPI urges the UK to address the skills shortage in STEM

Highly skilled scientific roles could move elsewhere if the situation is not addressed as a matter of urgency
Research & Development

Scotland’s manufacturing exports worth £462 million

The Scottish pharmaceutical industry is ‘booming’ and is now the second biggest spender on R&D, a new report has revealed
Research & Development

From molecule to medicine

Dr Sheuli Porkess, Deputy Chief Scientific Officer at the ABPI explains the importance of pharmaceutical research and what is involved in developing new medicines
Media

Embracing new innovation in the face of Brexit

Dr Paul Catchpole commented at the NICE Annual Conference that adopting innovations will help bring investment into the UK and crucially help get more NHS patients onto ground breaking clinical trials programmes
Research & Development

UK steps up its role in fighting global AMR

With 10 million people a year projected to die from antibiotic resistant infections by 2050, it is important that all partners, including the pharmaceutical industry, step up and work together to tackle this issue
Research & Development

At the frontier of brain tumour research, leave no stone unturned

With the Government set to invest an additional £20 million into the research, diagnosis and development of treatments for brain tumours, we need to talk more about how we are going to find the next blockbuster treatments for these devastating diseases says Dr Ali Hansford, Head of Science Policy at ABPI
Research & Development

New Lung Health Taskforce to tackle Britain’s third biggest killer

The Association of the British Pharmaceutical Industry (ABPI) and the British Lung Foundation (BLF) have launched a new Taskforce for Lung Health that will work, in collaboration, to produce a new national 5 year prevention, diagnosis and treatment plan for lung health
Subscribe now